|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Feb 1, 2025
|
FY2024
12 months to Feb 3, 2024
|
FY2023
12 months to Jan 28, 2023
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Research and development | ||||
| Sales and marketing | ||||
| General and administrative | ||||
| Lease modification, impairment, and related charges | ||||
| Legal settlement | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Interest income and other income, net | ||||
| Income (loss) before provision for income taxes | ||||
| Provision for income taxes | ||||
| Net loss | ||||
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustments, net of tax | ||||
| Unrealized gains on investments, net of tax | ||||
| Total other comprehensive income (loss) | ||||
| Comprehensive loss | ||||
| Basic and diluted net loss per share: | ||||
| Net loss per share, basic (in dollars per share) | ||||
| Net loss per share, diluted (in dollars per share) | ||||
| Weighted-average shares used in computing net loss per share, basic (in shares) | ||||
| Weighted-average shares used in computing net loss per share, diluted (in shares) | ||||
Loading...
